Manifold beneficial effects of acetyl salicylic acid and nonsteroidal anti-inflammatory drugs on sepsis

被引:60
作者
Eisen, Damon P. [1 ]
机构
[1] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia
关键词
Aspirin; NSAID; Sepsis; Aspirin triggered lipoxins; NF-kappa B; Mortality; ACUTE LUNG INJURY; NF-KAPPA-B; STAPHYLOCOCCAL ALPHA-TOXIN; PERFUSED RABBIT LUNGS; ASPIRIN-TRIGGERED LIPOXINS; CANINE ENDOTOXIN-SHOCK; TUMOR-NECROSIS-FACTOR; LOW-DOSE ASPIRIN; INFECTIVE ENDOCARDITIS; ACETYLSALICYLIC-ACID;
D O I
10.1007/s00134-012-2570-8
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Acetyl salicylic acid (ASA) and nonsteroidal anti-inflammatory drugs (NSAIDs) may have potential as adjunctive agents for sepsis. This review considers the large body of literature that indicates a basis for sepsis therapy with ASA and suggests an agenda for future intervention studies in sepsis prevention and treatment. ASA and NSAIDs have beneficial effects in numerous experimental models of sepsis. Low doses of ASA of 100 mg/day or less trigger synthesis of lipoxins that are anti-inflammatory and aid in resolution of inflammation. Higher doses of ASA and NSAIDs act to reduce NF-kappa B stimulation and inhibit numerous septic pathways. While a previous randomised controlled trial of ibuprofen failed to show a reduction in mortality in sepsis, it did reduce clinical manifestations of sepsis. More recent observational studies have shown reduction in sepsis or acute lung injury leading to lower mortality in ICU patients treated with ASA. Low-dose ASA appears to be beneficial in the prevention and treatment of sepsis and SIRS. If proven, this intervention would have a major, cost-effective impact on sepsis care.
引用
收藏
页码:1249 / 1257
页数:9
相关论文
共 78 条
[1]  
ADAMS T, 1982, CIRC SHOCK, V9, P481
[2]  
ALMQVIST PM, 1984, CIRC SHOCK, V13, P227
[3]   Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis [J].
Anavekar, Nandan S. ;
Tleyjeh, Imad M. ;
Anavekar, Nagesh S. ;
Mirzoyev, Zaur ;
Steckelberg, James M. ;
Haddad, Christopher ;
Khandaker, Masud H. ;
Wilson, Walter R. ;
Chandrasekaran, Krishnaswamy ;
Baddour, Larry M. .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (09) :1180-1186
[4]   Effects of ibuprofen on the physiology and survival of hypothermic sepsis [J].
Arons, MM ;
Wheeler, AP ;
Bernard, GR ;
Christman, BW ;
Russell, JA ;
Schein, R ;
Summer, WR ;
Steinberg, KP ;
Fulkerson, W ;
Wright, P ;
Dupont, WD ;
Swindell, BB .
CRITICAL CARE MEDICINE, 1999, 27 (04) :699-707
[5]   Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: A host defense role for platelet microbicidal proteins [J].
Bayer, AS ;
Ramos, MD ;
Menzies, BE ;
Yeaman, MR ;
Shen, AJ ;
Cheung, AL .
INFECTION AND IMMUNITY, 1997, 65 (11) :4652-4660
[6]   The effects of ibuprofen on the physiology and survival of patients with sepsis [J].
Bernard, GR ;
Wheeler, AP ;
Russell, JA ;
Schein, R ;
Summer, WR ;
Steinberg, KP ;
Fulkerson, WJ ;
Wright, PE ;
Christman, BW ;
Dupont, WD ;
Higgins, SB ;
Swindell, BB .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (13) :912-918
[7]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[8]   PHARMACOKINETICS OF ENTERIC-COATED ASPIRIN AND INHIBITION OF PLATELET THROMBOXANE-A2 AND VASCULAR PROSTACYCLIN GENERATION IN HUMANS [J].
CERLETTI, C ;
MARCHI, S ;
LAURI, D ;
DOMANIN, M ;
LORENZI, G ;
URSO, R ;
DEJANA, E ;
LATINI, R ;
DEGAETANO, G .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (02) :175-180
[9]   Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes [J].
Cerletti, C ;
Dell'Elba, G ;
Manarini, S ;
Pecce, R ;
Di Castelnuovo, A ;
Scorpiglione, N ;
Feliziani, V ;
de Gaetano, G .
CLINICAL PHARMACOKINETICS, 2003, 42 (12) :1059-1070
[10]   A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis [J].
Chan, KL ;
Dumesnil, JG ;
Cujec, B ;
Sanfilippo, AJ ;
Jue, J ;
Turek, MA ;
Robinson, TI ;
Moher, D .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (05) :775-780